Cargando…
Mitochondrial transplantation: opportunities and challenges in the treatment of obesity, diabetes, and nonalcoholic fatty liver disease
Metabolic diseases, including obesity, diabetes, and nonalcoholic fatty liver disease (NAFLD), are rising in both incidence and prevalence and remain a major global health and socioeconomic burden in the twenty-first century. Despite an increasing understanding of these diseases, the lack of effecti...
Autores principales: | Chen, Yifei, Yang, Fuji, Chu, Ying, Yun, Zhihua, Yan, Yongmin, Jin, Jianhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9588235/ https://www.ncbi.nlm.nih.gov/pubmed/36273156 http://dx.doi.org/10.1186/s12967-022-03693-0 |
Ejemplares similares
-
Human umbilical cord mesenchymal stem cell-derived exosomes ameliorate liver steatosis by promoting fatty acid oxidation and reducing fatty acid synthesis
por: Yang, Fuji, et al.
Publicado: (2023) -
Fibroblast Growth Factors for Nonalcoholic Fatty Liver Disease: Opportunities and Challenges
por: Tian, Haoyu, et al.
Publicado: (2023) -
Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021) -
Challenges and opportunities in nonalcoholic steatohepatitis
por: Wang, Xiaobo
Publicado: (2022) -
Obesity and nonalcoholic fatty liver disease: current perspectives
por: Sarwar, Raiya, et al.
Publicado: (2018)